Vein ablation is an effective treatment for patients with bleeding varicose veins

Cardella, Jonathan; Aurshina, Afsha; Sumpio, Bauer E.; Zhuo, Haoran; Zhang, Yawei; Dardik, Alan; Chaar, Cassius Iyad Ochoa

doi:10.1016/j.jvsv.2022.03.015

Cited by 6 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…If timely recognized, bleeding VVs can be effectively treated using open and/or endovascular procedures [ 9 ]. Therefore, it is important that all patients with bleeding VVs should be referred immediately to vascular surgery services [ 10 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Risk Factors for Bleeding Varicose Veins in Patients with Chronic Venous Disease

et al. 2023

View full text Add to dashboard Cite

Background and Objectives: Chronic venous disease (CVD) is a widespread clinical condition that is very common in western countries in the adult general population with a wide range of clinical manifestations, such as varicose veins (VVs) that in certain circumstances may complicate with rupture and subsequent bleeding that may even be fatal. The aim of this study is to evaluate risk factors for bleeding VVs. Materials and Methods: This is a retrospective study conducted in patients with CVD complicating with bleeding of VVs over a 4-year period (2019–2022). A random sample, for the same 4-year period and with a 3:1 ratio, was selected from other CVD patients without VVs bleeding that served as the control group. Results: From a global population of 1048 patients with CVD over a 4-year period, a total of 33 patients (3.15%) with VVs bleeding were selected. A group of 99 patients without VVs bleeding were randomly selected from the total population of 1048 patients with CVD. Findings of this study showed that advanced clinical stage of CVD (i.e., C4b stage), advanced age, living alone, suffering from cardiovascular co-morbidity (i.e., hypertension and CHF), assuming certain drugs that act on blood coagulation (i.e., aspirin, anticoagulants), assuming psychotropic medication, having particular venous reflux patterns (i.e., below-knee GSV reflux, non-saphenous veins reflux, Cockett’s perforators reflux), and not having been assessed and treated previously for CVD (i.e., with VADs, CT, or surgery) may predispose a high risk for bleeding VVs. Conclusions: Bleeding VVs may be a life-threatening complications of CVD patients, and monitoring risk factors found in this study and others that, hopefully, may be discovered in the future through further focused research will help to reduce the impact of this problem in this patient population.

show abstract

Section: Discussionmentioning

confidence: 99%

“…In fact, 1 out of 1000 autopsies for sudden death are due to bleeding for ruptured VVs [ 6 ]. Nevertheless, in the current literature, there are also some case series describing non-fatal hemorrhage from ruptured VVs [ 7 , 8 , 9 ]. Overall, the general reported incidence of bleeding VVs ranges from 3% to 9.1% [ 10 ].…”

Section: Introductionmentioning

confidence: 99%